Insider Transactions in Q2 2022 at Gilead Sciences, Inc. (GILD)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 10
2022
|
Merdad Parsey Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
485
-1.14%
|
$29,100
$60.74 P/Share
|
|
Jun 10
2022
|
Merdad Parsey Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,039
+2.38%
|
-
|
|
Jun 10
2022
|
Daniel Patrick O'Day Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,539
-0.61%
|
$92,340
$60.74 P/Share
|
|
Jun 10
2022
|
Daniel Patrick O'Day Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,300
+1.29%
|
-
|
|
Jun 10
2022
|
Brett A Pletcher EVP,Corp Affairs & Gen Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
280
-0.83%
|
$16,800
$60.74 P/Share
|
|
Jun 10
2022
|
Brett A Pletcher EVP,Corp Affairs & Gen Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
782
+2.27%
|
-
|
|
Jun 10
2022
|
Diane E. Wilfong SVP, Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
148
-0.55%
|
$8,880
$60.74 P/Share
|
|
Jun 10
2022
|
Diane E. Wilfong SVP, Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
317
+1.16%
|
-
|
|
Jun 10
2022
|
Johanna Mercier Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
462
-1.3%
|
$27,720
$60.74 P/Share
|
|
Jun 10
2022
|
Johanna Mercier Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
990
+2.71%
|
-
|
|
Jun 10
2022
|
Andrew D Dickinson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,969
-2.85%
|
$118,140
$60.74 P/Share
|
|
Jun 10
2022
|
Andrew D Dickinson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,672
+3.28%
|
-
|
|
May 05
2022
|
Harish Manwani Director |
SELL
Payment of exercise price or tax liability
|
Direct |
477
-4.78%
|
$29,097
$61.35 P/Share
|
|
May 05
2022
|
Harish Manwani Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,444
+19.68%
|
-
|
|
May 05
2022
|
Anthony Welters Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,444
+28.82%
|
-
|
|
May 05
2022
|
Javier Rodriguez Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,444
+27.31%
|
-
|
|
May 05
2022
|
Kevin E Lofton Director |
BUY
Grant, award, or other acquisition
|
Indirect |
2,444
+2.5%
|
-
|
|
May 05
2022
|
Jeffrey Bluestone Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,444
+29.98%
|
-
|
|
May 05
2022
|
Jacqueline K Barton Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,444
+10.73%
|
-
|
|
May 03
2022
|
Anthony Welters Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,223
+38.24%
|
-
|
|
May 03
2022
|
Javier Rodriguez Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,223
+35.38%
|
-
|
|
May 03
2022
|
Kevin E Lofton Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,223
+2.34%
|
-
|
|
May 03
2022
|
Harish Manwani Director |
SELL
Payment of exercise price or tax liability
|
Direct |
349
-4.43%
|
$20,940
$60.33 P/Share
|
|
May 03
2022
|
Harish Manwani Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,223
+22.01%
|
-
|
|
May 03
2022
|
Sandra Horning Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,112
+38.94%
|
-
|
|
May 03
2022
|
Jeffrey Bluestone Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,223
+40.51%
|
-
|
|
May 03
2022
|
Jacqueline K Barton Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,223
+11.05%
|
-
|
|
Apr 28
2022
|
Kevin E Lofton Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
16,322
+15.28%
|
$408,050
$25.62 P/Share
|